Rhinovirus |
Picornaviridae |
RNA virus |
100+ |
Year round with fall and spring peaks |
45% |
Coronavirus |
Coronaviridae |
Enveloped RNA virus |
3 |
Year round with winter peak. Summer outbreaks have been described. |
25% |
Influenza virus |
Orthomyxoviridae |
Enveloped RNA virus |
3 |
Annual epidemic in winter in temperate climates. In tropical climates there may be multiple outbreaks. |
14% |
Adenovirus |
Adenoviridae |
Double-stranded, non-enveloped DNA virus |
49 |
Sporadic. Epidemics and endemic disease are more prevalent in the late winter, spring, and summer. |
5% |
Parainfluenza virus |
Paramyxoviridae |
Enveloped RNA virus |
4 |
Winter peaks for Parainfluenza 1 and 2; summer peaks for Parainflunza 3 |
5% |
Respiratory syncytial virus |
Paramyxoviridae, but lacks neuraminidase and hemagglutinin surface glycoproteins |
Enveloped RNA virus |
2 (A and B) |
Epidemics are mainly in winter and early spring but may be sporadic throughout the year. |
1% |
Human metapneumovirus |
Paramyxoviridae |
RNA virus |
2 |
It was initially thought that epidemics occurred between December and April; however, it has been extended to all year round. |
Unknown |
Mycoplasma pneumoniae |
|
Smallest free-living microorganisms |
1 |
Pleomorphic and ubiquitous in animals and plants; prone to outbreaks throughout the world, at any season |
|
Chlamydia pneumoniae |
Antigenically, genetically, and morphologically distinct from other Chlamydia species. |
All isolates seem to be closely related serologically. |
1 |
Worldwide distribution, with no evidence of seasonality or known animal reservoir |
|
A new name has been proposed: Chlamydophila pneumoniae
|